Skip to main content
Equibles

IPHA · Innate Pharma SA · Financials

Track IPHA — free

Use IPHA with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research IPHA.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$1.39 +0.06 (+4.51%) Play latest call Q2 2026 earnings call transcript
Rebalance outlook locked
Market Cap
$148.56M
Shares
111.70M
Volume · Nov 4 10.67K Avg daily vol (3M) 158.14K

Income-statement, balance-sheet and cash-flow figures from SEC filings, plus a debt profile anchored in the latest 10-K and updated by each 10-Q and debt exhibit.

Pull these statements through the financial statements API or MCP →
Revenue
9.01M -55.2%
FY2025 Revenue FY2017–FY2025
Net Income
-49.18M +0.6%
FY2025 Net Income FY2017–FY2025
Operating Margin
-599.76% -343.4pp
FY2025 Operating Margin FY2017–FY2025
Diluted EPS
-0.55 +9.8%
FY2025 Diluted EPS FY2017–FY2025
Operating Cash Flow
-52.76M -665%
FY2025 Operating Cash Flow FY2017–FY2025

Chart any reported metric, KPI or segment over time — the full statement history lives here

Income Statement Balance Sheet Cash Flow All Metrics
Annual Quarterly
Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018 FY2017
EUR 9.01M 20.12M 61.64M 57.67M 24.7M 69.77M 85.45M 93.95M 44.03M
EUR 43.62M 51.98M 56.02M 51.66M 47M 49.71M 62.9M 69.56M 67M
EUR 519K 353K 368K 660K 472K 504K 592K 518K 649K
EUR 19.39M 19.72M 18.29M — — — — 18.14M —
EUR 1.38M 1.99M 5.09M 4.42M 4.57M 9.39M 13.74M 7.4M 4.4M
EUR -54.01M -51.58M -12.67M -57.43M -47.83M 1.08M 1.58M 5.15M -39.98M
EUR 3.12M 3.98M 1.84M 5.32M 4M 6.76M 4.98M 8.43M 10.54M
EUR -49.18M -49.47M -7.57M -57.97M -45.48M -829K 7.87M 2.72M -48.02M
EUR 0 0 0 0 0 0 0 -333K 368K
EUR -49.18M -49.47M -7.57M -58.1M -52.81M -63.98M -20.76M 3.05M -48.39M
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.

Debt Profile

Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.

Read debt and covenant terms in your AI or your code through MCP and the API →

Reported debt balances

Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.

Reported balanceAs ofAmountSource
Current borrowings, including current portion of noncurrent borrowings 2026-06-30 EUR 2,100 6-K filed 2026-09-17
Instrument and agreement coverage is incomplete. Additional filings are awaiting review.

Covenants

Covenant terms have not yet been verified for this profile.

The balance figures do not establish whether covenants apply or whether the company complies with them.

Loans, facilities and notes

The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.

Key facts CIK 1598599 CUSIP 45781K204 13F (30d) 4 filings 4 filers Visit website Investor relations